Julie Heng is a JD candidate at Stanford University studying emerging technology policy and regulatory reform. As an adjunct fellow and former research associate at the Center for Strategic and International Studies, she focuses primarily on the U.S. science and technology ecosystem, biotechnology governance, and regional innovation. Previously, she was a public interest technology fellow at the Federal Trade Commission’s Bureau of Consumer Protection, an investigative journalism apprentice at the Detroit Free Press, and an intern with the Washtenaw County Division of Public Works. She graduated with highest honors in evolutionary biology and philosophy at Harvard University, where she researched antimicrobial resistance and cancer evolution.
All Julie Heng Content
Filter by
The United States Cannot Win the Twenty-First-Century Innovation Race with a Twentieth-Century Playbook
Commentary by Sujai Shivakumar and Julie Heng — July 30, 2025
The United States Cannot Win the Twenty-First-Century Innovation Race with a Twentieth-Century Playbook
Podcast Episode by Sujai Shivakumar and Julie Heng — July 30, 2025
Renewing the United States’ Skilled Technical Workforce
Podcast Episode by Sujai Shivakumar and Julie Heng — July 9, 2025
Renewing the United States’ Skilled Technical Workforce
Critical Questions by Sujai Shivakumar and Julie Heng — July 9, 2025
The NSF Is a Key National Security Pillar—Now Is Not the Time to Disarm
Podcast Episode by Sujai Shivakumar and Julie Heng — May 1, 2025
The NSF Is a Key National Security Pillar—Now Is Not the Time to Disarm
Commentary by Sujai Shivakumar and Julie Heng — May 1, 2025
Sustaining Standards Leadership: The United States Cannot Disengage from RISC-V
Report by Sujai Shivakumar and Julie Heng — April 28, 2025
Innovation Lightbulb: Tracking CHIPS Act Incentives
Newsletter by Chris Borges, Yutong Deng, and Julie Heng — April 25, 2025
Innovation Lightbulb: Not Just Attracting But Retaining International STEM Students
Newsletter by Julie Heng and Yutong Deng — April 11, 2025
Understanding the National Security Commission on Emerging Biotechnology Report
Commentary by Julie Heng — April 8, 2025